Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.91M | -9.04M | -15.12M | -8.50M | -10.56M |
| Total Depreciation and Amortization | 28.00K | 27.00K | 66.00K | 86.00K | 86.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.89M | 1.83M | 9.25M | 2.24M | 2.12M |
| Change in Net Operating Assets | 18.00K | -3.05M | -988.00K | -1.68M | -805.00K |
| Cash from Operations | -7.97M | -10.23M | -6.79M | -7.85M | -9.16M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 3.00K | 1.00K | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.12M | 19.50M | -2.89M | 8.59M | -59.16M |
| Cash from Investing | -3.12M | 19.50M | -2.89M | 8.59M | -59.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 217.00K | -- | -- | 134.00K | -- |
| Repurchase of Common Stock | -- | -185.00K | -196.00K | -- | -116.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 217.00K | -185.00K | -196.00K | 134.00K | -116.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.88M | 9.08M | -9.87M | 874.00K | -68.43M |